Evonik to Cease Amino Acid Production in Hungary
Evonik has revealed plans to stop its amino acid production at its Hungarian Kaba site by the end of April 2018. The facility is run by Evonik subsidiary, Evonik Agroferm Zrt, which currently employs about 120 people.
Evonik said the decision to cease production was prompted by “intense and increasing competition” in the market for the amino acid L-threonine, produced in Kaba under the ThreAMINO brand name. “Despite considerable and continual optimisations, it is no longer possible for Evonik to maintain economic production in Kaba over the long term. Therefore, we have decided to stop production in Kaba which is in line with our strategy to secure a leading position for our amino acid business,” said Dr. Emmanuel Auer, head of Evonik’s animal nutrition business line.
The company said it had explored other alternatives before taking the decision to shut down the unit. “The further use of the site will be explored and decided on in close cooperation with the Hungarian authorities after production has stopped,” it added.
ThreAMINO is added to animal feed to ensure an optimally balanced supply of amino acids.
2026-10-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF and Evonik Rumored Potential Acquisition or Merger
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
Evonik to Close Two German Plants, Further Cutting Europe’s High-Purity Silicon Tetrachloride Capacity
-
Multiple Chemical Industry Leaders Post Strong H1 Earnings Growth as Sector Profitability Revives
-
Evonik Inaugurates New Speciality Alumina Plant in Japan, Bolstering Regional Growth Strategy
-
Evonik and AMSilk Expand Collaboration to Develop Sustainable Biotech Silk Materials
-
Evonik Launches Asia’s First Alkoxide Plant in Jurong Island
-
Evonik Converts Epoxy Hardener Production to 100% Renewable Electricity
-
Breakup! Vland Biotech and Evonik Part Ways as GHS Joint Venture Falls Short of Expectations
-
Evonik Completes Shift to Green Electricity for Polybutadiene Production at its Marl, Germany, Plant
Recommend Reading
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
Lipoid Kosmetik Announces New U.S. Market Distribution Partnership with Omya
-
BASF Technology with CFRP Lands in Nanjing: High-Performance Dispersant Production Line Officially Commissioned
-
Remote Cost Fluctuations September ABS Prices Show Increases
-
Costs Rise, Consumption Stagnates: PC Prices in September Fell After an Increase
-
Cost Volatility & Supply Tightening: PP Prices Surge and Consolidate in September
-
Glycopyrronium: Pharmaceutical Applications, Mechanism, and Chemical Specs
-
Crude Oil Boosts Gasoline and Diesel Prices in Shandong Refineries, China